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INTRODUCTION
Computed tomography (CT) is being investigated for a variety of radiologic tasks involving
lung nodules and lung malignancies. These activities include using low-dose CT as a screening
tool for the early detection of lung cancer in high risk populations (1,2), evaluating the response
of primary and metastatic lung lesions to various therapies (3) and characterizing indeterminate
nodules as benign or malignant (4,5,6). Radiologists are faced with the task of both identifying
and characterizing lung nodules on large, multidetector row CT scans for these applications.
This has motivated interest and research into computer-aided diagnosis (CAD) methods, with
several commercial systems having either already received FDA approval or that have been
submitted for approval of CAD or CAD-like systems.
To further stimulate research and development activities in this area, the National Cancer
Institute (NCI) formed the Lung Image Database Consortium – the LIDC (7–9). The mission
of the LIDC is: (a) to develop an image database as a web accessible international research
resource for the development, training, and evaluation of CAD methods for lung cancer
detection and diagnosis using CT and (b) to create this database to enable the correlation of
performance of CAD methods for detection and classification of lung nodules with spatial,
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temporal and pathological ground truth. The intent of this database is to hasten advancement
of lung nodule CAD research by (1) providing clinical images to investigators who might not
have access to patient images and (2) creating a reference database that will support the relative
comparison of different CAD systems performance, thus eliminating database composition as
a source of variability in system performance (10). This database requires the collection of an
appropriate set of scans, and the creation of “truth” for each scan.
The LIDC decided that information about the presence or absence of lung nodules, and the
spatial extent of nodules when present, should be provided for each scan in the LIDC database.
To obtain the best estimate of spatial truth, expert thoracic radiologists analyzed and annotated
each of the collected CT scans. (Note that the LIDC also intends to provide histopathological
“truth” for each scan in which this data becomes available). Previous research (11–14) has
indicated that there is considerable variability among even expert readers in both the detection
and boundary delineation of lung nodules on CT (15). This variability has been observed in
many similar tasks, both in determining nodule size through estimating volume or measuring
unidimensional or bidimensional lesion size to assess disease progression (16–21).
While the issue of inter-reader variability is widely recognized, the typically accepted solution
to this problem is to form an expert review panel. However, this usually involves having a
number of radiologists (typically an odd number greater than or equal to three) review each
scan first independently, and then when there is disagreement, to jointly come together to arrive
at a consensus decision. The goal of the LIDC is to annotate several hundred CT scans by
thoracic radiologists at geographically separate centers. Therefore, obtaining spatial truth using
ongoing consensus panels seemed to be a difficult, if not impossible, task. Consensus panels
frequently reflect the opinion of the “strongest” member of the panel, as a recognized weakness
of this approach. In addition, the truth panel approach does not capture the variability and
uncertainty between readers, which may be of interest to a wide variety of lung nodule studies.
Therefore, the LIDC designed a two-phase data collection process that would: (a) allow
multiple expert readers to review each scan; (b) unambiguously express the nodule location
and spatial extent information acquired from each review in the form of expert annotations;
(c) allow for and express differences between readers in the identification of nodules and the
variability in the delineation of nodule boundaries; (d) allow the data collection process to be
performed asynchronously so that all radiologists need not participate in the review of a single
scan at the same instant in time. The purpose of this manuscript is to describe the design and
implementation of the two-phase reading approach used by the LIDC in its data collection.
MATERIALS AND METHODS
Definitions of objects to be marked and annotation requirements
Before the review process could be implemented, the LIDC Steering Committee had to resolve
exactly what would be marked during the review. The first step was to define what is meant
by a “nodule”. While there were several definitions available, the LIDC decided that these
defintions needed to be supplemented and clarified, especially in the context of screening and
diagnosis of lung cancer using thin section CT imaging.. In the context of the LIDC data
collection process, these defintions needed to be specific so that the annotation instructions
could be provided to the radiologists who performed these tasks.
The term “nodule” (7) represents a spectrum of abnormalities (irrespective of presumed
histology), which is itself a subset of a broader spectrum of abnormalities termed “focal
abnormality;” a lesion should be considered a “nodule” if it satisfies the definition of
“nodule” (the most essential component of which is its "nodular" morphology). The LIDC
developed a nodule visual library to assist with this very visual definition (22). Nodules may
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represent primary lung cancers, metastatic disease, or non-cancerous processes. As part of the
LIDC inclusion criteria, it was agreed that scans nominated for inclusion in the LIDC database
should have between zero and six lung nodules, each with a maximum diameter of 30 mm.
Based on the clinical experience of the radiologists within the LIDC, a decision was made to
distinguish between nodules ≥ 3 mm and < 3 mm. In addition, many low-dose, thin-section
CT scans demonstrate many “non-nodule” objects that could be confused with nodules.
Therefore, the LIDC decided to create three categories of objects to be marked:
1. Nodules ≥ 3 mm in diameter, regardless of presumed histology
2. Nodules < 3 mm in diameter of an indeterminate nature
3. Non-nodules ≥ 3 mm in diameter
Nodules that are < 3mm but are clearly benign (i.e. solidly calcified) were specifically excluded
from being marked, as were non-nodules < 3mm. Each of the included categories is described
below along with the annotation requirements for each. This is summarized in Table 1.
Nodules ≥ 3 mm, regardless of presumed histology
Nodules ≥ 3 mm in diameter (Figure 1) are characterized fully, including:
• Drawing the full boundary of the nodule in three dimensions using each slice on which
it appears. From this full boundary, other measures could be derived such as maximum
diameter, nodule volume and mathematical descriptors of shape.
• The specific instructions to radiologists were to “Draw an outline around the nodule
in all sections in which it appears, with the pixels that comprise the outline at the first
pixel outside the nodule”. This was done to ensure consistent drawing across
radiologists and across software tools.
• The radiologist also subjectively assessed each nodule’s characteristics such as its
subtlety, internal structure, spiculation, lobulation, shape (sphericity), texture, margin
and subjectively assessed likelihood of malignancy. These are described in detail
below.
Nodules < 3 mm
A very large number of such objects could potentially exist for nodules < 3 mm (Figure 2).
Since these lesions are too small to accurately contour or characterize,
• Only a single mark (an approximate centroid) was placed and only on such nodules
that were not clearly benign (not solidly calcified).
• No subjective assessment of nodule characteristics would be performed.
Non-Nodules ≥ 3 mm
In addition to marking nodules, some objects that might be confused with nodules but were
clearly not nodules would be marked as well. These include linear band-like opacities, scars,
atelectasis, post surgical changes, or a nexus region of scars and other objects that are not
nodules. Since the inclusion criteria limited nodules to 30 mm objects, if a lesion exceeding
30 mm in diameter was located in the scan, it was marked as a non-nodule ≥ 3mm. For these
objects (just as for nodules < 3 mm):
• Only a single mark (an approximate centroid) would be drawn.
• No subjective assessment would be performed.
• An example of some non-nodules ≥ 3 mm is shown in Figure 3.
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Design of the Multiple Reader, Multiple Session Process
The LIDC data collection process model started from several basic requirements to establish
the best possible information concerning the location and spatial extent of lung nodules: (a)
that multiple readers be allowed to review each individual CT scan; (b) that no forced consensus
would be imposed; and (c) that reviews be performed in a distributed and asynchronous fashion.
To facilitate this review process, the LIDC adapted a decentralized data communication model,
illustrated in Figure 4. Rather than submit all scans to a central archive or to the NCI, each site
is responsible for nominating scans from its clinical/research image archive with appropriate
IRB approval and then distributing these scans to the other sites for review. These scans are
nominated according to criteria spelled out in (7). The site that nominated and distributed the
scan is called the “Requesting Site”. In this decentralized model, the other four sites act as
“Servicing Sites” for this scan, performing the required reviews (described below). Because
each site is responsible for both supplying scans (as the Requesting Site) and reviewing scans
sent by other sites (as the Servicing Site), each site will perform Requesting Site activities for
its own scans and Servicing Site activities for scans sent to it for review by other sites. In this
model, a Requesting Site does not review scans from its own institution, thereby eliminating
any possibility of prior knowledge of the clinical outcome of the scan. Requesting Site
responsibilities extended beyond scan nomination to managing the scan through the reading
process (below) until all the required annotation and other information (such as diagnosis
obtained from pathology) is obtained.
Blinded Reading Phase
The LIDC designed a two-phase reading approach to provide the best estimate of nodule
location and spatial extent. In the first phase, referred to as the “Blinded Read phase”, the
Requesting Site sends the scan to each Servicing Site for review. At each Servicing Site, one
reader reviews the CT scan independently, without any information as to what readers at other
sites have detected or marked; thus they are blinded to the results of other readers. This first
phase is performed asynchronously and no coordination is required between readers. For each
Blinded Read session, the reader reviews the scan, identifying and annotating all nodules and
non-nodules. Figure 5 illustrates example annotations from a Blinded Read session.
When the Blinded Reading session is completed at each Servicing Site, the annotations are
captured in a standard format (see below) and sent to the Requesting Site, which then compiles
the annotations for the Blinded Read phase and records them in a local database.
Unblinded reading phase
In the second phase, known as the “Unblinded Read phase,” the Requesting Site sends out the
compiled blinded read annotations to the readers who reviewed the scan in the Blinded Read
Phase. Each reader then re-reviews the scan, but this time the reader is shown both their own
blinded read annotations and all of the blinded review annotations of the other readers, thereby
being “unblinded” to the annotations of the other readers. The annotations are labeled so that
each reader knows which annotations are their own and which are from other reader; the
annotations of the other readers are anonymized. An example of the unblinded review interface
is illustrated in Figure 6.
The reader now performs a second review of each scan and decides for each annotation to
either: (a) accept their original annotation without alteration, (b) add an annotation (e.g., if they
missed an object that another reader marked as a nodule), (c) delete an annotation or (d) modify
the boundaries of an annotation. The Unblinded Reading phase also required each reader to
subjectively characterize several properties of each nodule ≥ 3mm using a set of descriptors:
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• Subtlety - difficulty of detection
• Internal structure – internal composition of the nodule (soft tissue, fluid, fat, air)
• Calcification – pattern of calcification, if present
• Sphericity – the three-dimensional shape of the nodule in terms of its roundness
• Margin – description of how well-defined the margin is
• Lobulation – the degree of lobulation ranging from none to marked
• Spiculation – the extent of spiculation present
• Radiographic solidity – internal texture (solid, ground glass or mixed)
• Malignancy - subjective assessment of the likelihood of malignancy, assuming the
scan originated from a 60-year-old male smoker.
An example interface is shown in Figure 7. This figure illustrates that each of the above
characteristics are rated on a five-point scale, except for internal structure and calcification.
For some of the categories, descriptive terms were used for all five possible responses; for
others, no descriptive terms were associated with the five possible responses. For example, a
numeric value is available if the reader wants to score a lesion’s sphericity somewhere between
“ovoid” and “round”, though no satisfactory descriptive term could be found.
When this reading phase is completed, the results of each reader’s Unblinded Read are
compiled into a standardized format (see below) and then sent to the Requesting Site. The
results of the Unblinded Read are collected from all four Servicing Sites and then sent on to
the National Cancer Insitute’s Image Archive (NCIA) for entry into the publically available
database. It should be noted that when all four Unblinded Read results are available, they can
be compared to determine: (a) how many radiologists detected each nodule (which can be used
to determine an objective measure of subtlety) and (b) the variation of contours between readers
(as described in [15]).
IMPLEMENTATION AND INFRASTRUCTURE
Prequisites
IRB approval was obtained for each institution that allowed for the inclusion of anonymized
data in the LIDC database. The inclusion criteria for patients, nodules and acceptable CT scan
technical parameters and image quality were specified [7]. All subjective assessment categories
and vocabulary terms were defined, as well as how to code the responses in a standardized
fashion.
Anonymization of CT image data
For each scan submitted for LIDC review and inclusion in the public database, the Requesting
Site managed the anoymization of the scan. This involved removing protected health
information (PHI) and any site identifiers from the original DICOM image files. To comply
with the DICOM standard, fields were either replaced with anonymized values, set to NULL
or removed completely, depending on the DICOM type of the field being anonymized. For
example, patient name and identifiers were replaced with LIDC-assigned values, while patient
birth date was set to NULL. Certain fields, such as study date, were handled in such a way as
to preserve temporal information without retaining any of the original information. For a patient
with multiple studies, the date of the first study was arbitrarily set to January 1, 2000, and any
subsequent scans were assigned dates offset from January 1, 2000 (i.e. either before or after
January 1, 2000) so that they preserved the actual time interval from the original study. In this
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way actual dates were removed, while preserving the relevant time offset information. This
anonymization was performed at each site and tested among the LIDC sites for compliance.
XML-based specification of annotations
To support the data collection process, the LIDC developed a portable and interchangeable file
format implemented in XML. The XML schema was designed to unambiguously represent the
results of all readers’ reviews of each CT. Each XML file contains information about:
a. the CT being reviewed ( instance UID)
b. the type of reading session (blinded or unblinded)
c. reader id
d. results from the reading session, where a reading session consists of a set of
annotations placed by a single reader during a single phase
e. for each nodule ≥ 3 mm marked by a reader, both the nodule characteristics and the
complete volumetric boundary are reported in the following manner:
1. nodule id – a unique id for the nodule marked by this reader
2. the radiologist-assessed characteristics of the nodule
3. the 3D volumetric boundary is completely defined by a of 2D regions of
interest (ROIs) for each slice in the nodule:
a. the overall format is to report each ROI z-position (longitudinal
direction) on which the nodule is visualized and the x- and y-
coordinates of the connected boundary points within each x-y
plane which define the ROI.
4. radiologists could describe regions of exclusion (primarily regions of air
within a nodule), where the exclusion ROIs are subtracted from the nodule .
f. For each nodule < 3 mm marked by this reader, ONLY a single point is reported:
1. a nodule id – a unique id for the nodule marked by this reader
2. Nodule Contour ROI – For nodules < 3 mm, this will consist of a single
(x,y,z) position that represents the approximate centroid of that nodule
g. For each non-nodule ≥ 3 mm marked by this reader, ONLY a single point is reported.
The data for non-nodules ≥ 3mm are similar to data recorded for nodules < 3 mm, but
can be uniquely identified by a code within the XML file. This description uses data
structures similar to the nodules described above:
1. a non-nodule id – a unique id for the non-nodule marked by this reader
2. location - this also consists of a single position (x,y,z) that represents the
centroid point of the non-nodule marked by the reader.
The complete specification for the XML file is described by its schema and documentation,
which can be found on the NCIA website (see http://ncia.nci.nih.gov/collections/ for more
details and documentation).
Messaging System
To faciltiate the decentralized communication system, the LIDC used this XML file format for
several purposes: (a) blinded read request messages from a Requesting Site to each Servicing
Site, (b) blinded read response messages from each Servicing Site back to the Requesting Site,
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(c) unblinded read request messages to the Servicing Sites and (d) unblinded read response
messages back to the Requesting Site. For each of these messages, the XML schema described
above was used with different values in key fields (such as request type). For the blinded read
request, there is no existing reading information (i.e., no information about nodule contours,
etc.); therefore the request message consisted of information about the CT scan only. For the
blinded read response, the message contains the information about the CT scan, reader and all
annotations.
For the unblinded read request, information about the CT scan as well as the compiled blinded
read responses are contained within the request file. This message contains all of the
information necessary for the annotation tools (as described below) to display the results of
the blinded reads, which are required to perform the unblinded reading.
For the unblinded read response, the contents of the file were similar in design to the results
of the blinded read response – the results of only one reader’s annotations. This response file
was sent back to the Requesting Site and compiled with other unblinded read responses. It is
the compiled results from the unblinded read responses that are the basis for the XML files
distributed to the NCI for release as part of the publicly available database.
Software Tools for Annotation
Software tools for image review and marking were developed based on non-commercial,
existing software packages. One of these employed purely manual tracing of nodules, while
two others employed semi-automated approaches in defining nodule boundaries.
Each of the three systems met the same LIDC internal specifications. These specifications
included the ability to read in and display CT imaging studies, basic image manipulation
functions (window/level, zoom, pan, cine view) and other important functions such as viewing
DICOM headers to verify technical parameters (such as slice thickness, etc.). Other
components of the specification included:
a. tools to draw, visualize and edit nodule boundaries, whether manual, semi-automated
or fully automated
b. the ability to create a region of interest (ROI) for each nodule ≥ 3 mm from boundary
tracings generated from the annotation tools described in (a),
c. tools to mark the approximate centroid of an object (for any nodule < 3 mm and non-
nodules ≥ 3 mm),
d. the ability to read in and display ROIs drawn by other radiologists at other institutions
(for unblinded reads).
RESULTS
This two-phase data collection process was designed, tested and implemented at all five LIDC
sites. This process has been used by the LIDC for over 500 CT scans to date. Currently,
approximately 100 scans are publicly available, with the remaining scans to be made public in
the near future. Each CT scan has been reviewed and marked by four readers using this blinded
and unblinded review model. Currently, the image data and XML files that contain the
unblinded read results from all four readers are publicly available from the NCIA Archives
(http://ncia.nci.nih.gov) under the LIDC collection.
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CONCLUSION
To date, the LIDC has created a publicly available database of approximately 100 thoracic CT
scans that have been marked for the location and spatial extent of lung nodules. Each scan was
reviewed by four radiologists, each at a different institution. The marking process involved
contouring nodules ≥ 3 mm in diameter, marking the centroid of nodules < 3 mm in diameter
and also marking other objects (labeled as non-nodules) that were ≥ 3 mm in diameter, but that
were not considered to be lung nodules. To establish this database, the LIDC created a unique
two-phase data collection process as well as the infrastructure to support that data collection
process; the effectiveness of this type of reading model has been shown in previous work [23].
The data collection process has been designed, tested and implemented; it has been used for
the annotation of all scans that are included in the NCIA image archive. This data collection
process will continue to be used by the LIDC, and approximately 1000 scans will ultimately
be collected through the LIDC and related efforts. Currently, image data and XML files
containing the annotations of each reader are available at that website. In the near future, other
information such as probability maps (or pmaps) (as described in [15]), pathological diagnosis
(whenever available) and other information will be available as well.
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Figure 1.
Example of a nodule ≥ 3 mm (arrowhead)
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Figure 2.
Example of a nodule < 3 mm (arrow)
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Figure 3.
Example of non-nodules ≥ 3 mm (apical scars indicated by arrows)
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Figure 4.
Diagram showing the distributed communication model used by the LIDC. Each of the five
sites has its own local imaging archive, from which it draws images to be supplied to the LIDC.
Each site communicates with each other site in a two-way fashion (solid two-way arrows).
Each site also communicates in a one-way fashion (dashed arrows) with the NCIA Image
Archive by submitting completed scans (image data, annotation, etc.) for which it was the
requesting site.
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Figure 5.
This figure shows examples of the annotations by LIDC readers during the Blinded Read phase
and includes: (a) the contouring of a nodule ≥ 3mm (the same nodule that was shown in Figure
1), (b) the marking of an approximate centroid for a nodule < 3mm (the same nodule < 3mm
that was shown in Figure 2); and (c) the marking of non-nodules ≥ 3mm (the same non-nodule
apical scars that were shown in Figure 3).
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Figure 6.
(a) This figure shows one of the annotation tools used to implement the LIDC unblinded read
review process. In this implementation, the compiled annotation results from the Blinded Read
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phase are displayed in a worklist on the right hand side. These marks are color coded in two
different ways: (1) Under the description column, objects that spatially overlap – and therefore
are assumed to represent the same marked objerct – are grouped together in alternating green
and white colored background labels. (2) For each object, the right hand column is color coded
so that: the reader’s own marks from the Blinded Read are in blue, other reader’s marks are in
red, pink is used to represent objects that overlap an object in the same group and green
represents objects already approved for the unblinded read (which by default includes all non-
nodules as these do not have to be matched or reviewed); (b) This shows an example of the
multiple contours that result from the Blinded Read, where the blue contour is that of the current
reader and contours of other readers are shown in red and pink..
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Figure 7.
This figure shows an example implemtation of the user interface where the radiologist was to
provide the subjective assessment of the nodule’s characteristics. Note that this was only used
for nodules ≥ 3mm.
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Table 1
Summary of Categories of Objects to be Marked and the Annotation Requirements
Category Annotation Subjective Assessment
Nodule ≥ 3mm (Fig 1) Draw Complete Contour Yes (Figure 7)
Nodule < 3mm (Fig 2) Mark approximate centroid None
Non-Nodule ≥ 3 mm (Fig 3) Mark approximate centroid None
Non-Nodule < 3 mm No marking None
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